Zyprexa MDL Class Wants Court To Name Doctors

Law360, New York (April 30, 2009, 12:00 AM EDT) -- At a hearing Friday in the Zyprexa multidistrict litigation, counsel for a class of third-party payors urged the court to divulge the names of physicians who may have overprescribed the drug at the behest of Eli Lilly & Co. representatives, while the pharmaceutical company argued the identities were immaterial to the case.

Judge Jack B. Weinstein of the U.S. District Court for the Eastern District of New York convened the hearing to decide whether the names of physicians should be released along with 132,000 call notes...
To view the full article, register now.

Related

Sections

Case Information

Case Title

In re: Zyprexa Products Liability Litigation


Case Number

1:04-md-01596

Court

New York Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Jack B. Weinstein

Date Filed

April 19, 2004

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.